E-128 Eye on the prize: trans-ophthalmic arterial embolizations of anterior cranial fossa dural arteriovenous fistulae
| Autor: | Nicholas A Telischak, Jeremy J Heit, M Marks, Eric S Sussman, Huy M. Do, Robert L. Dodd, Benjamin Pulli, Vera A. Mayercik |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Amaurosis fugax medicine.disease Neurovascular bundle Surgery medicine.anatomical_structure Anterior cranial fossa Dural arteriovenous fistulas Modified Rankin Scale Ophthalmic artery medicine.artery Medicine Posterior ischemic optic neuropathy Embolization medicine.symptom business |
| Zdroj: | Electronic Poster Abstracts. |
| DOI: | 10.1136/neurintsurg-2020-snis.160 |
| Popis: | Introduction Anterior cranial fossa dural arteriovenous fistulas (dAVFs) represent up to 10% of all dAVFs and have traditionally been treated surgically. These lesions derive their arterial supply from the bilateral anterior ethmoidal arteries (ophthalmic artery branches) in nearly all cases. Embolization via the ophthalmic artery poses unique technical challenges due to its small caliber and risk of vision loss. To date, there is a paucity of literature regarding the safety and efficacy of performing endovascular embolizations via the ophthalmic artery. Advances in endovascular therapy, including highly trackable microcatheters and balloon microcatheters, offer the potential for safe and successful embolization via the ophthalmic artery. Here we describe our experience of anterior cranial fossa dAVF treatment by endovascular embolization via the ophthalmic artery. Materials and Methods We conducted a retrospective cohort study of consecutive patients with anterior cranial fossa dAVF treated by ophthalmic artery embolization at two neurovascular centers from 2012 to 2020. Primary outcome was angiographic cure of the dAVF. Secondary outcome measures included vision loss, modified Rankin Scale at 90-days, mortality, and any other iatrogenic treatment complications. Results 10 patients met inclusion criteria, which included 8 male and 2 females. Mean patient age was 61.9 (SD 8.0) years. DAVF Cognard grades were: II (1 patient), III (5 patients), and IV (4 patients). 4 patients presented with cerebral hemorrhage due to the dAVF. 6 patients presented with headache, aphasia, amaurosis fugax, or were asymptomatic and incidentally discovered. The most commonly embolized arterial feeding vessels were the anterior and posterior ethmoidal arteries (n=8) and the recurrent meningeal artery (n=2). Embolysates included Onyx (8 cases), nBCA glue (1 case), and a combination of coils and Onyx (1 case). 4 cases were performed with balloon microcatheters. Complete dAVF cure was achieved in 9 patients (90%). Two patients had delayed washout of the ophthalmic artery after embolization which was treated with aspirin without subsequent visual defect. No patients experienced vision loss, death, or permanent disability. One patient experienced a minor complication of blurry vision in the left hemi-field suggestive of posterior ischemic optic neuropathy. 90 day mRS was 0 (7 patients), 1 (2 patients), and not yet available for one patient. Conclusions Anterior cranial fossa dAVF embolization can be safely performed through the ophthalmic artery with high angiographic cure rates and a low risk of vision loss or other complications. Disclosures V. Mayercik: None. N. Telischak: None. E. Sussman: None. B. Pulli: None. R. Dodd: None. M. Marks: None. H. Do: None. J. Heit: None. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|